Meat Institute Submits Comments Regarding FDA's Proposed Changes to Track Antimicrobial Sales and Distribution DataMonday, November 20, 2017
(North American Meat Institute)
The Meat Institute submitted comments in response to the Food and Drug Administration's (FDA) proposal to use a biomass denominator to adjust annual data regarding the amount of antimicrobials sold or distributed for use in food-producing animals in the U.S. The purpose of the proposed biomass denominator is to provide estimates of annual antimicrobial drug sales adjusted for the size of the animal population (the animal biomass) potentially being treated with those drugs. FDA believes these adjusted estimates will provide insight into shifts in the amount of antimicrobials sold for use in food-producing animals and will give the agency a better understanding of why sales increase or decrease over time.
In its comments, the Meat Institute contends antimicrobial sales data will not provide useful or accurate information about the shifts in antimicrobial use and resistance. The Meat Institute instead recommends that FDA support USDA's Antimicrobial Resistance Action Plan to "collect useful data that will help livestock procurers and veterinarians become even more judicious in their use of antimicrobials in their animals."share on facebook share on twitter